bilaterals.org logo
bilaterals.org logo

health

Thai CSOs’ letter to the EU chief negotiator regarding concerns over the ongoing FTA negotiation with Thailand
29-Nov-2024 Access to medicines
Civil society and non-government organizations in Thailand oppose the provisions proposed by the EU that will have a vast and adverse impact on access to medicines, universal health coverage scheme, agriculture, food sovereignty, consumer protection, and livelihoods of Thai people.
Civil society groups unite to monitor the 4th round of Thailand-EU FTA negotiation
26-Nov-2024 Thaiplus Net
Thai civil society groups, including FTA Watch and the Thai Network of People Living with HIV/AIDS, have expressed serious concerns over the ongoing Thailand-EU Free Trade Agreement negotiations. Key issues include stricter intellectual property rights, which could impact access to affordable medicines, and potential threats to food security and public health. The groups are urging the Thai government to prioritize public health and environmental concerns over corporate interests.
Thai and Swiss civil society unite to protect access to medicines and the Universal Health Coverage Scheme
21-Nov-2024 ITPC Global
Civil society groups in Thailand and Switzerland are urging the Thai government to maintain its stance against TRIPS+ provisions, which exceed the requirements of the World Trade Organization’s TRIPS Agreement. These groups argue that such provisions could significantly increase the cost of medicines and limit access for the Thai population.
Trump’s plan for US providers in NHS could scupper hopes of free trade deal
8-Nov-2024 i
Republicans’ Project 2025 manifesto suggests opening up NHS to ’foreign competition’.
India, Cambodia discuss investment treaty, UPI collab: Commerce ministry
24-Jun-2024 Busines Standard
India and South East Asian nation Cambodia deliberated upon diversification of the trade basket by identifying new products, bilateral investment treaty, recognition of Indian pharmacopoeia and collaboration in the pharma sector.
India’s newly amended patent rules threaten affordable medicines in the Global South
2-May-2024 Peoples Dispatch
It is no coincidence that just five days before the amendments were announced, India signed a Free Trade Agreement with the European Free Trade Association.
MSF response to signing of EFTA-India trade agreement
15-Mar-2024 MSF
MSF is concerned that certain clauses related to intellectual property in this trade deal could significantly undermine the use of existing public health measures enshrined in Indian patent law.
After 30 Years of NAFTA, the Working Classes Are Still Losing
1-Mar-2024 The Nation
Thirty years after NAFTA came into effect in 1994, the economic data suggests a somber conclusion: The three countries’ working classes are worse off today than they were before
Swiss trade deal: Is India changing its tune on pharma patents?
27-Feb-2024 SWI
Intellectual property protection for the Swiss pharmaceutical industry has been a key sticking point in negotiations on a free trade agreement with India. Now there seems to be a breakthrough in talks after 16 years. What’s changed?
Thorny clause in ripening India-European Free Trade Association deal may hit generic drug industry
14-Feb-2024 The Hindu
The clause in the draft free trade agreement text could delay access to affordable, generic versions of patented drugs in India by a minimum of six years, according to documents.
New patent rules in India-UK trade agreement will prioritise pharmaceutical profit over public health
13-Feb-2024 AFTINET
The “TRIPS-Plus” provisions in the India-UK Agreement are a dangerous attempt to increase the power of pharmaceutical companies by placing profits before public health.
EFTA-India FTA: Article on protection of undisclosed information (intellectual property chapter draft, Jan 2024)
12-Feb-2024
Letter: Civil society calls on UK Prime Minister to ensure UK-India free trade agreement does not threaten access to affordable medicines
23-Jan-2024 MSF
MSF and over 50 UK-based civil society organisations and individuals sent this open letter to United Kingdom Prime Minister, urging him to commit that the UK-India Free Trade Agreement will not gut the public health safeguards that are in India’s intellectual property laws.
The US push for GMO corn is out to lunch
4-Dec-2023 Common Dreams
So-called “Free trade” promises lower prices and more supply, but it derails food security. Mexico has been fighting this since the United States began a dispute over genetically modified corn.
India-UK free trade agreement faces hurdle over medical devices
21-Nov-2023 NDTV
Finalising the rules of origin for the medical devices sector remains a sticking-point in the proposed free-trade agreement between India and the UK and the talks are on to iron out the differences, an official said.
US escalates trade dispute over GM corn, challenges Mexico’s food sovereignty
18-Aug-2023 IATP
US Trade Representative office’s move to form dispute resolution panel lacks justification according to experts.
EU-Mercosur: Banned pesticides found on Brazilian limes in EU
21-Apr-2023 Greenpeace
A Greenpeace Germany study of Brazilian limes sold in the EU has found residues of several pesticides, some of them banned for use in Europe.
Free trade deal is a major threat to UK public health, warn experts
13-Apr-2023 Medical Press
The UK’s decision to join one of the world’s largest free trade agreements, known as the Comprehensive and Progressive Agreement on Trans-Pacific Partnership, poses a major threat to UK public health, warn experts.
Clamour against United Kingdom’s free-trade negotiator
20-Mar-2023 The Telegraph
Groups from India and nearly 40 countries express concern about a leaked chapter from the proposed FTA that they say appears to represent ‘a wish list’ of the pharmaceutical industry.
Health CSO statement on Kenya _US STIP
28-Feb-2023 Health CSO statement on Kenya _US STIP
We are part of a think tank that advocates for increased access to essential medicines by ensuring that intellectual property laws and policies do not create unnecessary barriers to access to affordable essential medicines, especially for people living with and affected by HIV and TB.